[
    "<p><strong>PROTOCOL</strong></p><p><strong>&nbsp;</strong></p><p>\u00b7&nbsp;Composition of duplex RTqPCR mastermixes (final volume of RTqPCR reaction of 20 \u00b5l)</p><p><strong>&nbsp;</strong></p><p><strong>Beta RTqPCR</strong></p><p>2x",
    "One Step: 10 \u00b5l</p><p>Forward primer 10\u00b5M: 0.8 \u00b5l (400 nm)</p><p>Reverse primer 10\u00b5M: 0.8 \u00b5l (400 nm)</p><p>Probe_Beta 10\u00b5M: 0.4 \u00b5l (200 nm)</p><p>Probe_NoBeta 10\u00b5M: 0.4 \u00b5l (200 nm)</p><p>Takara Ex Taq: 0.4 \u00b5l&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Prime Script Enzyme: 0.4 \u00b5l</p><p>H<sub>2</sub>O PCR: 1.8 \u00b5l</p><p>Extracted RNA: 5 \u00b5l</p><p><br></p><p><strong>Gamma RTqPCR</strong></p><p>2x",
    "One Step: 10 \u00b5l</p><p>Forward primer 10\u00b5M: 0.8 \u00b5l (400 nm)</p><p>Reverse primer 10\u00b5M: 0.8 \u00b5l (400 nm)</p><p>Probe_Gamma 10\u00b5M: 0.4 \u00b5l (200 nm)</p><p>Probe_NoGamma1 10\u00b5M: 0.2 \u00b5l (100 nm)</p><p>Probe_NoGamma2 10\u00b5M: 0.2 \u00b5l (100 nm)</p><p>Takara Ex Taq: 0.4 \u00b5l&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Prime Script Enzyme: 0.4 \u00b5l</p><p>H<sub>2</sub>O PCR: 1.8 \u00b5l</p><p>Extracted RNA: 5 \u00b5l</p><p><br></p><p><strong>Delta",
    "RTqPCR</strong></p><p>2x",
    "One Step: 10 \u00b5l</p><p>Forward primer 10\u00b5M: 0.8 \u00b5l (400 nm)</p><p>Reverse primer 10\u00b5M: 0.8 \u00b5l (400 nm)</p><p>Probe_Delta 10\u00b5M: 0.4 \u00b5l (200 nm)</p><p>Probe_NoDelta 10\u00b5M: 0.4 \u00b5l (200 nm)</p><p>Takara Ex Taq: 0.4 \u00b5l&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Prime Script Enzyme: 0.4 \u00b5l</p><p>H<sub>2</sub>O PCR: 1.8 \u00b5l</p><p>Extracted RNA: 5 \u00b5l</p><p><br></p><p>\u00b7&nbsp;Controls to be included in each RTqPCR assay:</p><p><br></p><p>- 2 wells with 5 \u00b5l of nuclease-free water (RTqPCR negative controls)</p><p>- 2 wells with 5 \u00b5l of RNA extraction negative control (RNA extraction negative controls)</p><p>- 1 well with 5 \u00b5l of each corresponding synthetic SARS-CoV-2 RNA controls at 1000 copies/\u00b5L (RTqPCR positive controls)</p><p><br></p><p>\u00b7&nbsp;For each sample, 2 wells of undiluted RNA and 2 wells of 1/10 dilution are analyzed.</p><p><br></p><p>\u00b7&nbsp;For quantification of each target, standard curves are constructed, using a minimum of 5 10-fold dilutions and 3 wells for each dilution, using 2 synthetic SARS-CoV-2 RNA controls as reference materials (one corresponding to the variant containing the specific mutation and another corresponding to a variant without the specific mutation).</p><p><br></p><p>\u00b7&nbsp;Thermocycler conditions (common for all duplex RTqPCR assays)&nbsp;</p><p>- 10 min at 50\u00baC (x1)</p><p>- 3 min at 95\u00baC (x1)</p><p>- 3 sec at 95\u00baC and 30 sec at 60\u00baC (x45)</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><strong>INTERPRETATION OF RESULTS</strong></p><p><br></p><p><strong><em>a)&nbsp;&nbsp;&nbsp;&nbsp;RTqPCR controls (see Tables 2, 3, 4)</em></strong></p><p><br></p><p><strong><em>b)&nbsp;&nbsp;&nbsp;&nbsp;Samples</em></strong></p><p><strong><em>&nbsp;</em></strong></p><p>\u00b7&nbsp;The calculation of each specific SARS-CoV-2 target concentration in genome copies per reaction (gc/rxn) in each well is performed using the standard curve.</p><p>\u00b7&nbsp;Occurrence of inhibition and calculation of mean viral titers are estimated by comparing concentrations obtained from duplicate wells tested for the two RNA dilutions (undiluted RNA and 1/10 dilution), as described in Carcereny et al., 2021 (1).",
    "Mean concentration of samples and standard error are calculated using as many data as possible, taking into consideration the following steps:</p><p><br></p><p>a<strong>.&nbsp;</strong>Calculate mean concentration as gc/rxn for each RNA dilution:</p><p>ai.",
    "Data from RNA dilutions containing \u201cNo Cq\u201d or Cq\u226540 in both wells are not be used for calculation.</p><p>aii.&nbsp;When in the analysis of the 2 wells of any RNA dilution, one of the wells has a Cq value &lt;40 and the other has \"No Cq\" or Cq\u226540, this last well is assigned a concentration equal to the theoretical limit of detection (LoD) of 1 gc/rxn.</p><p><br></p><p>b<strong>.",
    "</strong>Calculate mean concentration as gc/rxn for each sample:</p><p>bi.",
    "When the difference between the concentration estimated from undiluted RNA and 1/10 dilution is &lt; 0.5 log<sub>10</sub>, mean concentration of sample is calculated using data from the 4 wells.</p><p>bii.&nbsp;When",
    "the difference between the concentration estimated from undiluted RNA and 1/10 dilution is \u2265 0.5 log<sub>10</sub>, inhibition is considered and mean concentration of sample is calculated using data from the 1/10 dilution.</p><p>&nbsp;</p><p>\u00b7&nbsp;The proportion of SARS-CoV-2 genomes corresponding to variants containing the specific signature mutation is calculated using the formula:</p><p><em>&nbsp;</em></p><p><em>",
    "Beta Duplex RTqPCR: </em></p><p>&nbsp;</p><p>% = gc/rxn (Probe_Beta) /",
    "[gc/rxn (Probe_Beta) + cg/rxn (Probe_NoBeta)] x 100</p><p>&nbsp;</p><p><em>Gamma Duplex RTqPCR: </em></p><p>&nbsp;</p><p>% = gc/rxn (Probe_Gamma) /",
    "[gc/rxn (Probe_Gamma) + cg/rxn (Probes_NoGamma (1+2)] x 100</p><p>&nbsp;</p><p><em>Delta Duplex RTqPCR: </em></p><p>&nbsp;</p><p>% = gc/rxn (Probe_Delta) /",
    "[gc/rxn (Probe_Delta) + cg/rxn (Probe_NoDelta)]",
    "x 100</p><p>&nbsp;</p><p>\u00b7",
    "Cases in which any of the concentrations fall below the limit of quantification (LoQ), the percentage is calculated using the corresponding LoQ.",
    "When both concentrations are &lt;LoQ, percentage cannot be estimated.</p><p><br></p><p><br></p>"
]